gut response glp 1 support GLP-1 Daily GLP-1 and Gut Health: Addressing

Most GLP-1 care still happens in person

[6] Tirzepatide (Mounjaro): up to 15 mg once weekly for type 2 diabetes, and up to 15 mg once weekly for chronic weight management (marketed as Tirzepatide)

It is contraindicated in patients with a personal or family history of medullary thyroid cancers (MTC) or patients with multiple endocrine neoplasia syndrome type 2 (MEN2).[30] FUTURE INDICATIONS AND TRIALS Oral semaglutide has been explored with higher doses of 25 and 50 mg in ongoing PIONEER plus trials.[39] Another trial under the name PIONEER TEEN is ongoing to see the efficacy and safety of semaglutide in children and teenagers with age 10 years to 17 years.[40] PIONEER REAL is a global prospective, non-interventional single-arm real-world study with oral semaglutide.[41] EVOKE and EVOKE plus are ongoing trials to see the effect of oral semaglutide in Alzheimers disease.[42] SOUL is an ongoing CV superiority trial with an objective to prove CV benefits with this molecule

CNS stimulants, including amphetamine, have been associated with the onset or exacerbation of motor and verbal tics

And gallbladder issues are a known risk with rapid weight loss from any cause, not just GLP-1 medications

Apply moisturizer to damp skin after bathing to enhance hydration retention